How does pulsed-field ablation compare with radiofrequency and cryoablation for atrial fibrillation treatment?

Pulsed-field ablation selectively targets cardiac tissue while sparing adjacent structures like the esophagus and phrenic nerve, reducing complication rates observed with thermal methods. Early pivotal data show comparable efficacy with shorter procedure times [11]. Read More

What procurement criteria should hospitals prioritize when selecting a transcatheter valve platform?

Hospitals should evaluate valve durability data beyond five years, compatibility with existing imaging infrastructure, and the manufacturer's proctor-training support. Total cost of ownership — including inventory consignment terms — often matters more than unit price [9]. Read More

How are cybersecurity regulations affecting connected implantable device design?

FDA's 2023 Refuse to Accept policy requires premarket cybersecurity documentation for all cyber-enabled devices. Manufacturers must now embed software bill-of-materials transparency and patch-update mechanisms into device architecture before submission [17]. Read More

What role do clinical registries play in post-market cardiovascular device surveillance?

Registries like STS/ACC TVT and NCDR CathPCI provide real-world outcome benchmarking that influences coverage decisions and identifies device-specific safety signals earlier than traditional adverse-event reporting [11]. Read More

How can device companies address the interventional cardiologist shortage in emerging markets?

Simulation-based training platforms, tele-proctoring during live cases, and simplified device-delivery systems lower the procedural learning curve. Partnerships with academic medical centers accelerate workforce development [16]. Read More

What financing models help hospitals in low-income countries acquire advanced cardiovascular equipment?

Vendor-managed inventory, pay-per-procedure leasing, and multilateral development-bank health-infrastructure loans enable capital-constrained facilities to access modern platforms without large upfront outlays [12]. Read More

How might gene-therapy-device convergence reshape the Cardiovascular Devices Market by 2035?

Catheter-delivered gene therapies for heart failure and inherited cardiomyopathies require specialized delivery systems, creating a new device sub-segment. Early-stage programs from academic-industry partnerships could reach pivotal trials by 2030 [14]. Read More

What is the current size of the cardiovascular devices market?

The cardiovascular devices market reached USD 66.55 billion in 2025 and is projected to reach USD 109.50 billion by 2035. Read More

What is the CAGR of the cardiovascular devices market?

The cardiovascular devices market is projected to grow at a CAGR of 5.10% during the forecast period 2026–2035. Read More

Which region leads the cardiovascular devices market?

North America holds the largest share at 48.0%, while Asia-Pacific is the fastest-growing region at 9.1% CAGR. Read More

Cardiovascular Devices Market (2026 - 2035)

ID: MRFR/HC/10338-HCR

200 Pages

Rahul Gotadki

Last Updated: July 06, 2026

Cardiovascular Devices Market Research Report: Size, Share, Trend Analysis By Device Type (Diagnostic Devices, Monitoring Devices, Therapeutic Devices, Surgical Devices), By Applications (Coronary Artery Disease, Heart Failure, Arrhythmia, Valvular Heart Disease), By End Users (Hospitals, Cardiac Centers, Ambulatory Surgical Centers, Home Healthcare), By Technology (Implantable Pacemakers, Cardiac Stents, Ablation Devices, Heart Valve Devices) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Cardiovascular Devices Market

Market Size

Forecast Period2026-2035

CAGR (2026-2035)5.10%

2025 Market SizeUSD 66.55 Billion

2035 Market SizeUSD 109.50 Billion

Key Players

Medtronic plc

Abbott Laboratories

Boston Scientific

Edwards Lifesciences

Johnson & Johnson

Terumo Corporation

Trends

Rising CVD Prevalence and Aging Demographics
AI-Enhanced Diagnostics and Decision Support
Transcatheter Therapy Indication Expansion

Opportunities

AI-Powered Remote Cardiac Monitoring Platforms
Emerging-Market Hospital Infrastructure Buildouts
Transcatheter Mitral and Tricuspid Interventions

Summary Table of Contents Segmentation Methodology Download PDF

1 Market Overview |
1. 1.1 Study Assumptions & Market Definition |
2. 1.2 Scope of the Study |
3. 1.3 Research Methodology
2 Market Summary & Key Takeaways
3 Market Dynamics |
1. 3.1 Market Drivers Analysis | |
  1. 3.1.1 Rising CVD Prevalence and Aging Demographics | |
  2. 3.1.2 AI-Enhanced Diagnostics and Decision Support | |
  3. 3.1.3 Transcatheter Therapy Indication Expansion | |
  4. 3.1.4 Outpatient Migration to Ambulatory Surgical Centers | |
  5. 3.1.5 Emerging-Market Hospital Infrastructure Investment | |
  6. 3.1.6 Remote Patient Monitoring Reimbursement | |
  7. 3.1.7 Renal Denervation and Neurovascular Device Approvals |
2. 3.2 Market Restraints Analysis | |
  1. 3.2.1 High Device Acquisition and Procedural Costs | |
  2. 3.2.2 Regulatory Approval Timelines and Compliance Burden | |
  3. 3.2.3 Reimbursement Uncertainty for Novel Devices | |
  4. 3.2.4 Skilled Interventionalist Shortage | |
  5. 3.2.5 Cybersecurity Risks in Connected Implantables |
3. 3.3 Market Opportunity Analysis | |
  1. 3.3.1 AI-Powered Remote Cardiac Monitoring Platforms | |
  2. 3.3.2 Emerging-Market Hospital Infrastructure Buildouts | |
  3. 3.3.3 Transcatheter Mitral and Tricuspid Interventions | |
  4. 3.3.4 Data Monetization and Predictive Analytics | |
  5. 3.3.5 Bioresorbable and Drug-Eluting Next-Generation Stents |
4. 3.4 Industry Value Chain Analysis |
5. 3.5 Porter's Five Forces Analysis
4 Global Cardiovascular Devices Market Size & Forecast (2021–2035) |
1. 4.1 Historical Market Size (2021–2025) |
2. 4.2 Current & Forecast Market Size (2026–2035) |
3. 4.3 Market Size by Revenue (USD Billion) |
4. 4.4 Year-over-Year Growth Analysis
5 Segmentation Analysis |
1. 5.1 By Device Type | |
  1. 5.1.1 Diagnostic and Monitoring Devices | |
  2. 5.1.2 Therapeutic and Surgical Devices |
2. 5.2 By Application | |
  1. 5.2.1 Coronary Artery Disease | |
  2. 5.2.2 Structural Heart Disease | |
  3. 5.2.3 Arrhythmia | |
  4. 5.2.4 Heart Failure | |
  5. 5.2.5 Peripheral Vascular Disease |
3. 5.3 By End User | |
  1. 5.3.1 Hospitals & Cardiac Centers | |
  2. 5.3.2 Ambulatory Surgical Centers | |
  3. 5.3.3 Cardiac Diagnostic Centers
6 Regional Analysis |
1. 6.1 North America | |
  1. 6.1.1 United States | |
  2. 6.1.2 Canada | |
  3. 6.1.3 Mexico |
2. 6.2 Europe | |
  1. 6.2.1 Germany | |
  2. 6.2.2 United Kingdom | |
  3. 6.2.3 France | |
  4. 6.2.4 Italy | |
  5. 6.2.5 Spain | |
  6. 6.2.6 Nordic Countries | |
  7. 6.2.7 Russia | |
  8. 6.2.8 Rest of Europe |
3. 6.3 Asia-Pacific | |
  1. 6.3.1 China | |
  2. 6.3.2 India | |
  3. 6.3.3 Japan | |
  4. 6.3.4 South Korea | |
  5. 6.3.5 ASEAN | |
  6. 6.3.6 Rest of Asia-Pacific |
4. 6.4 South America | |
  1. 6.4.1 Brazil | |
  2. 6.4.2 Argentina | |
  3. 6.4.3 Rest of South America |
5. 6.5 Middle East & Africa | |
  1. 6.5.1 Saudi Arabia | |
  2. 6.5.2 UAE | |
  3. 6.5.3 South Africa | |
  4. 6.5.4 Egypt | |
  5. 6.5.5 Rest of MEA
7 Competitive Landscape |
1. 7.1 Market Share Analysis (2025) |
2. 7.2 Competitive Benchmarking Matrix |
3. 7.3 Company Profiles | |
  1. 7.3.1 Medtronic plc | |
  2. 7.3.2 Abbott Laboratories | |
  3. 7.3.3 Boston Scientific Corporation | |
  4. 7.3.4 Edwards Lifesciences Corporation | |
  5. 7.3.5 Johnson & Johnson (Biosense Webster) | |
  6. 7.3.6 Terumo Corporation | |
  7. 7.3.7 Cardinal Health Inc. | |
  8. 7.3.8 LivaNova PLC | |
  9. 7.3.9 MicroPort Scientific Corporation | |
  10. 7.3.10 Biotronik SE & Co. KG
8 Future Outlook & Strategic Recommendations (2026–2035) |
1. 8.1 AI-Autonomous Clinical Decision Support |
2. 8.2 Platform Economics and Device-as-a-Service |
3. 8.3 Miniaturization and Bioelectronic Convergence |
4. 8.4 Sustainability and Circular Device Models
9 Recent Developments & News
10 Frequently Asked Questions (FAQs)
11 Report Scope & Methodology |
1. 11.1 Study Period & Base Year |
2. 11.2 Data Sources & Citations |
3. 11.3 Abbreviations
12 LIST OF TABLES |
TABLE 1 Global Cardiovascular Devices Market Size & Forecast, by Revenue (USD Billion), 2021–2035 |
TABLE 2 Global Cardiovascular Devices Market — Year-over-Year Growth Analysis, 2021–2035 |
TABLE 3 Global Cardiovascular Devices Market — Driver Impact Analysis |
TABLE 4 Global Cardiovascular Devices Market — Restraint Impact Analysis |
TABLE 5 Global Cardiovascular Devices Market Size, by Device Type, 2021–2035 (USD Billion) |
TABLE 6 Global Cardiovascular Devices Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 7 Global Cardiovascular Devices Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 8 Global Cardiovascular Devices Market Size, by Region, 2021–2035 (USD Billion) |
TABLE 9 North America Cardiovascular Devices Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 10 Europe Cardiovascular Devices Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 11 Asia-Pacific Cardiovascular Devices Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 12 South America Cardiovascular Devices Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 13 Middle East & Africa Cardiovascular Devices Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 14 Competitive Benchmarking Matrix — Global Cardiovascular Devices Market, 2025 |
TABLE 15 Company Profiles — Key Players, Global Cardiovascular Devices Market |
TABLE 16 Recent Developments & Strategic Announcements, 2023–2025 |
TABLE 17 Report Scope & Methodology Summary |
TABLE 18 Detailed Sources and Citations |
TABLE 19 North America Cardiovascular Devices Market Size, by Device Type, 2021–2035 (USD Billion) |
TABLE 20 North America Cardiovascular Devices Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 21 North America Cardiovascular Devices Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 22 Europe Cardiovascular Devices Market Size, by Device Type, 2021–2035 (USD Billion) |
TABLE 23 Europe Cardiovascular Devices Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 24 Europe Cardiovascular Devices Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 25 Asia-Pacific Cardiovascular Devices Market Size, by Device Type, 2021–2035 (USD Billion) |
TABLE 26 Asia-Pacific Cardiovascular Devices Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 27 Asia-Pacific Cardiovascular Devices Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 28 South America Cardiovascular Devices Market Size, by Device Type, 2021–2035 (USD Billion) |
TABLE 29 South America Cardiovascular Devices Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 30 South America Cardiovascular Devices Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 31 Middle East & Africa Cardiovascular Devices Market Size, by Device Type, 2021–2035 (USD Billion) |
TABLE 32 Middle East & Africa Cardiovascular Devices Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 33 Middle East & Africa Cardiovascular Devices Market Size, by End User, 2021–2035 (USD Billion)
13 LIST OF FIGURES |
FIGURE 1 Cardiovascular Devices Market Dynamics — Drivers, Restraints & Opportunities |
FIGURE 2 Value Chain Analysis — Global Cardiovascular Devices Market |
FIGURE 3 Porter's Five Forces Analysis — Cardiovascular Devices Market |
FIGURE 4 Global Cardiovascular Devices Market Size Trend, 2021–2035 (USD Billion) |
FIGURE 5 Cardiovascular Devices Market Share, by Device Type, 2025 (%) |
FIGURE 6 Cardiovascular Devices Market Share, by Application, 2025 (%) |
FIGURE 7 Cardiovascular Devices Market Share, by End User, 2025 (%) |
FIGURE 8 Cardiovascular Devices Market Share, by Region, 2025 (%) |
FIGURE 9 North America Cardiovascular Devices Market Share, by Country, 2025 (%) |
FIGURE 10 Europe Cardiovascular Devices Market Share, by Country, 2025 (%) |
FIGURE 11 Asia-Pacific Cardiovascular Devices Market Share, by Country, 2025 (%) |
FIGURE 12 South America Cardiovascular Devices Market Share, by Country, 2025 (%) |
FIGURE 13 Middle East & Africa Cardiovascular Devices Market Share, by Country, 2025 (%) |
FIGURE 14 Competitive Landscape — Market Share Analysis, 2025 |
FIGURE 15 Competitive Positioning Matrix — Key Players, 2025

Certified Researchers

Customize Report

Segmentation Quick Reference

Dimension	Sub-Segments	Dominant Segment	Fastest Growing Segment
By Device Type	Diagnostic and Monitoring Devices; Therapeutic and Surgical Devices	Diagnostic and Monitoring Devices	Therapeutic and Surgical Devices
By Application	Coronary Artery Disease; Structural Heart Disease; Arrhythmia; Heart Failure; Peripheral Vascular Disease	Coronary Artery Disease	Structural Heart Disease
By End User	Hospitals & Cardiac Centers; Ambulatory Surgical Centers; Cardiac Diagnostic Centers	Hospitals & Cardiac Centers	Ambulatory Surgical Centers
By Region	North America; Europe; Asia-Pacific; South America; Middle East & Africa	North America	Asia-Pacific

Market Segmentation Overview

By Device Type

Sub-Segment	Key Trend
Diagnostic and Monitoring Devices	AI-algorithm integration driving upgrade cycles; portable ultrasound and wearable ECG proliferation
Therapeutic and Surgical Devices	Transcatheter valve expansion, leadless pacing, bioresorbable scaffolds entering pivotal trials

Diagnostic and monitoring devices encompass electrocardiography systems, echocardiography platforms, cardiac CT/MRI modules, Holter monitors, and emerging wearable rhythm sensors. The segment benefits from recurring software-upgrade revenue as AI compatibility becomes a procurement prerequisite.

By Application

Sub-Segment	Key Trend
Coronary Artery Disease	Drug-eluting stent evolution and physiology-guided PCI adoption
Structural Heart Disease	Transcatheter aortic, mitral, and tricuspid device pipelines maturing
Arrhythmia	Pulsed-field ablation and next-generation leadless pacemakers
Heart Failure	LVAD miniaturization and implantable hemodynamic sensors
Peripheral Vascular Disease	Drug-coated balloons and atherectomy innovation

Coronary artery disease dominates by revenue, but structural heart disease offers the highest growth trajectory as transcatheter therapies achieve regulatory clearance across progressively lower-risk patient populations.

By End User

Sub-Segment	Key Trend
Hospitals & Cardiac Centers	Hybrid OR buildouts and cath-lab volume consolidation
Ambulatory Surgical Centers	CMS procedure-list expansion enabling outpatient cardiac interventions
Cardiac Diagnostic Centers	Decentralized screening and AI-enabled remote interpretation

Hospitals remain the primary setting for complex cardiovascular interventions, but ambulatory surgical centers are the fastest-growing channel as reimbursement policies and lower-profile device designs enable same-day discharge for an expanding procedure set.

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”